Lawrence McDermott
Pulmonary Disease · Savannah, GANPI 1801838818
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $958,265 of the $962,533 with a category attached, or 99.6%. Teva Pharmaceuticals USA, Inc. accounts for 60.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $644,320 and has fallen 100.0% since, to $62 in 2025. Among pulmonary disease clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $18,161 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$582K
- AstraZeneca$233K
- Incyte Corporation$147K
- Madrigal Pharmaceuticals$62
What the payments were for
- Consulting fees$958,265100%
- Travel & lodging$4,2060%
- Education$620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $582,315 |
| AstraZeneca | 6 | $233,150 |
| Incyte Corporation | 43 | $147,006 |
| Madrigal Pharmaceuticals | 1 | $62 |
How this compares
$962,533 in reported general payments places this provider in the 95th percentile of 365 pulmonary disease providers in Georgia.
Other pulmonary disease in Savannah
- Michael MullinsSavannah$132K
- Michael PerkinsSavannah$67K
- Ryan MoodySavannah$50K
- Gifford LorenzSavannah$20K
- Vivek SambharaGainesville$417K
- Chad MillerAustell$382K
- Nehal BhattAthens$371K
- Maria MascoloRincon$358K
- Colin SwensonAtlanta$255K
- David MillerDecatur$206K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.